180 related articles for article (PubMed ID: 8625059)
1. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
Scaradavou A; Heller G; Sklar CA; Ren L; Ghavimi F
Cancer; 1995 Nov; 76(10):1860-7. PubMed ID: 8625059
[TBL] [Abstract][Full Text] [Related]
2. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.
Heyn R; Haeberlen V; Newton WA; Ragab AH; Raney RB; Tefft M; Wharam M; Ensign LG; Maurer HM
J Clin Oncol; 1993 Feb; 11(2):262-70. PubMed ID: 8426203
[TBL] [Abstract][Full Text] [Related]
3. A report on second neo-plasms in seven children with solid tumors.
Hu H; Zhang W; Li J; Li F; Li R; Liu Z; Huang D
Ann Ital Chir; 2022; 92():331-338. PubMed ID: 36052474
[TBL] [Abstract][Full Text] [Related]
4. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
6. Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience.
Estilo CL; Huryn JM; Kraus DH; Sklar CA; Wexler LH; Wolden SL; Zlotolow IM
J Pediatr Hematol Oncol; 2003 Mar; 25(3):215-22. PubMed ID: 12621240
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
8. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).
Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL
Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040
[TBL] [Abstract][Full Text] [Related]
9. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Friedman DN; Sklar CA; Oeffinger KC; Kernan NA; Khakoo Y; Marr BP; Wolden SL; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2013 Apr; 60(4):694-9. PubMed ID: 22911631
[TBL] [Abstract][Full Text] [Related]
10. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
[TBL] [Abstract][Full Text] [Related]
11. Second malignant neoplasms in children after treatment of soft tissue sarcoma.
Rich DC; Corpron CA; Smith MB; Black CT; Lally KP; Andrassy RJ
J Pediatr Surg; 1997 Feb; 32(2):369-72. PubMed ID: 9044156
[TBL] [Abstract][Full Text] [Related]
12. Secondary neoplasms after radiotherapy for a childhood solid tumor.
Paulino AC; Fowler BZ
Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
[TBL] [Abstract][Full Text] [Related]
13. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
14. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
[TBL] [Abstract][Full Text] [Related]
15. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
[TBL] [Abstract][Full Text] [Related]
16. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group.
Bisogno G; Sotti G; Nowicki Y; Ferrari A; Garaventa A; Zanetti I; Favre C; Schiavetti A; Tamaro P; Carli M
Cancer; 2004 Apr; 100(8):1758-65. PubMed ID: 15073867
[TBL] [Abstract][Full Text] [Related]
19. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
20. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
